Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lycoramine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104592243B details a novel Sc(OTf)3 catalyzed route for Galantamine. Discover cost reduction in API manufacturing and reliable pharmaceutical intermediates supply.
Patent CN102532149A details a novel asymmetric synthesis for galanthamine and lycoramine. Discover cost-effective, scalable routes for high-purity API manufacturing.
Patent CN102532149B details a scalable asymmetric synthesis for Galanthamine. This report analyzes cost reduction in API manufacturing and supply chain reliability for pharmaceutical intermediates.